unconjugated bilirubin is nothing but indirect bilirubin? what are pot

unconjugated bilirubin is nothing but indirect bilirubin? what are potential causes of isolates indirect bilirubin increase post illeal resection with stoma closure post 6-7 months due to crohns. bwel habits are good and healthy on adalimumab every 2 weeks s.c injection liver biopsy done no pbsc and no wilsons

Reading File

Finding Sources

Reading File

Finding Sources

I now have comprehensive source material. Let me synthesize a thorough answer.

Unconjugated = Indirect Bilirubin: Yes, with a nuance

Yes, unconjugated bilirubin and indirect bilirubin refer to the same fraction, but there is a technical distinction worth knowing:

"Direct" and "indirect" are terms from the van den Bergh diazo reaction: conjugated bilirubin reacts directly with the diazo reagent; unconjugated bilirubin reacts only indirectly (after addition of an accelerant like methanol).
"Indirect bilirubin" = Total bilirubin − Direct bilirubin (a calculated value by subtraction).
Unconjugated bilirubin is actually slightly underestimated by the indirect bilirubin test, because the direct fraction also includes small amounts of delta-bilirubin (bilirubin covalently bound to albumin).

In clinical practice, the two terms are used interchangeably, which is acceptable.

— Harrison's Principles of Internal Medicine 22E, Measurement of Serum Bilirubin; Miller's Anesthesia 10e, Serum Bilirubin; Harper's Biochemistry 32e, Measurement of Bilirubin in Serum

Causes of Isolated Indirect (Unconjugated) Hyperbilirubinemia in Your Patient

This patient's specific context: Crohn's disease → ileal resection with stoma → stoma closure ~6–7 months ago → good bowel habits → on adalimumab → liver biopsy negative for PBSC (primary biliary sclerosing cholangitis) and Wilson's disease.

The differential is structured mechanistically:

1. Gilbert's Syndrome (most likely, especially if mild elevation)

The most common cause of isolated unconjugated hyperbilirubinemia in adults, affecting 3–5% of the population. Caused by a UGT1A1 promoter polymorphism → reduced bilirubin UDP-glucuronosyltransferase (UDPGT) activity (~30% of normal) → impaired conjugation. Bilirubin typically stays 2–3 mg/dL, rarely >5 mg/dL.

Why it rises in this patient's context:

Fasting, illness, physiologic stress, and inflammatory states all precipitate or worsen Gilbert's syndrome
Post-surgical recovery, Crohn's disease flares, and altered gut motility after stoma closure can all act as triggers
Adalimumab itself does not cause unconjugated hyperbilirubinemia, but systemic inflammatory states do

— Henry's Clinical Diagnosis, Derangements of Bilirubin Metabolism; Harrison's 22E, Isolated Elevation of Serum Bilirubin

2. Enhanced Enterohepatic Bilirubin Recirculation Post-Ileal Resection

This is mechanistically specific and underappreciated:

Conjugated bilirubin secreted into bile normally travels to the terminal ileum and colon, where bacterial β-glucuronidases deconjugate it → unconjugated bilirubin → reduced to urobilinogen → ~80–90% excreted in stool, ~10–20% undergoes enterohepatic cycling.
After ileal resection, the anatomy is disrupted. Following stoma reversal (reestablishment of continuity), there can be altered bacterial colonization of the reconstituted gut, changes in transit time, and an altered microbiome, all of which affect β-glucuronidase activity and the rate of bilirubin deconjugation and reabsorption.
In Crohn's disease with ileal disease/resection, the enterohepatic recycling of bilirubin is augmented, contributing to increased unconjugated bilirubin load delivered to the liver.
Harrison's explicitly notes: "Enterohepatic recycling of bilirubin in ileal disease states contributes to [pigment stone] pathogenesis" — the same mechanism can raise serum unconjugated bilirubin.

— Harrison's 22E, Gallstones; Sleisenger and Fordtran's GI and Liver Disease, Intestinal Factors; Harriet Lane Handbook, Indirect Hyperbilirubinemia (lists ileal atresia/resection under enterohepatic recirculation causes)

3. Hemolysis (must exclude)

Any hemolytic process overwhelms the liver's conjugation capacity → predominantly unconjugated bilirubinemia. Causes to consider in a Crohn's patient on adalimumab:

Drug-induced hemolytic anemia (rare with adalimumab/anti-TNF agents)
Autoimmune hemolytic anemia — Crohn's disease has extra-intestinal manifestations including AIHA
Vitamin B12/folate deficiency (common after terminal ileal resection → megaloblastic anemia with ineffective erythropoiesis and intramedullary hemolysis)
Iron deficiency with ongoing occult blood loss

Indirect bilirubin levels in hemolysis are typically 1.5–3.0 mg/dL in adults. Check: CBC with reticulocyte count, peripheral smear, LDH, haptoglobin, direct Coombs test.

— Henry's Clinical Diagnosis, Causes of Elevated Serum Levels of Unconjugated Bilirubin

4. Vitamin B12 Deficiency / Megaloblastic Ineffective Erythropoiesis

Highly relevant here: The terminal ileum is the exclusive site of vitamin B12 (cobalamin) absorption (via intrinsic factor receptors). After ileal resection, B12 malabsorption is near-universal unless supplemented. Megaloblastic anemia causes intramedullary hemolysis (destruction of abnormal erythroid precursors in the bone marrow before they enter circulation), which raises unconjugated bilirubin without overt hemolysis on the peripheral smear. This can persist for months even after stoma closure if B12 stores are depleted.

Check: Serum B12, folate, MCV, homocysteine, methylmalonic acid.

5. Crigler-Najjar Syndrome Type II (Arias Syndrome) — Rare

Partial deficiency of UGT1A1 (more severe than Gilbert's). Can present in adults with unconjugated hyperbilirubinemia. Less likely here given the liver biopsy and clinical context, but worth noting as a genetic differential if Gilbert's genetics are tested and negative.

6. Adalimumab-Related Considerations

Adalimumab (anti-TNF-α) is not a known cause of unconjugated hyperbilirubinemia. It can rarely cause drug-induced liver injury (DILI) with conjugated hyperbilirubinemia and elevated transaminases, not isolated indirect.
The negative liver biopsy makes significant hepatic pathology (PSC, Wilson's) unlikely, consistent with your workup.
However, adalimumab can reactivate HBV — screen if not already done.

Summary Table

Cause	Mechanism	Likelihood in this patient
Gilbert's syndrome	↓ UGT1A1 activity, triggered by stress/fasting/inflammation	High — most common; worsened by post-surgical state
Enterohepatic bilirubin recirculation	Altered gut microbiome post-ileal resection/stoma reversal → ↑ deconjugation and reabsorption	High — anatomically specific
B12 deficiency / megaloblastic ineffective erythropoiesis	Intramedullary hemolysis from terminal ileal resection	High — nearly universal after ileal resection
Hemolysis (AIHA or other)	Overwhelms hepatic conjugation capacity	Moderate — Crohn's extra-intestinal manifestation
Crigler-Najjar Type II	Near-absent UGT1A1	Low
Adalimumab DILI	Drug-induced liver injury	Very low (would be conjugated, not unconjugated)

Practical Next Steps

Check B12 and folate levels + MCV — ileal resection makes B12 deficiency nearly inevitable without supplementation
CBC with reticulocyte count, LDH, haptoglobin, peripheral smear — to exclude hemolysis
UGT1A1 genotyping — confirms Gilbert's if clinically suspected
Quantify bilirubin level — if <3 mg/dL with normal LFTs, Gilbert's + post-resection recirculation is the most parsimonious explanation
HBV serology — before/during adalimumab use

The liver biopsy ruling out PBSC and Wilson's is reassuring and essentially excludes significant hepatic structural pathology. The most clinically important diagnostic priorities in this specific patient are B12 deficiency and Gilbert's syndrome.

hbv also neg

Good — HBV negative further narrows the picture and effectively rules out reactivation hepatitis as a contributor.

With that, the working differential tightens considerably:

Refined Differential (HBV Neg, Liver Biopsy Neg, Good Bowel Habits)

Most Likely (top 3)

1. Gilbert's Syndrome + Inflammatory/Post-surgical Trigger The combination of Crohn's disease activity, post-operative recovery from stoma closure (~6–7 months ago), and biologic therapy creates a sustained low-grade physiologic stress environment that persistently unmasks or worsens Gilbert's. If bilirubin is in the 1.5–3 mg/dL range with completely normal ALT/AST/ALP/GGT, this is the most parsimonious explanation. UGT1A1 genotyping confirms it cheaply and definitively.

2. Subclinical B12 Deficiency → Ineffective Erythropoiesis After terminal ileal resection, B12 absorption is lost permanently. Even if the patient feels well and bowel habits are good, B12 stores deplete over 2–5 years (sometimes faster post-surgery). Megaloblastic ineffective erythropoiesis causes intramedullary red cell destruction → unconjugated bilirubin rises without overt anaemia necessarily being present yet. This is frequently missed because B12 deficiency is not always checked routinely post-resection.

Key point: B12 deficiency can elevate unconjugated bilirubin before anaemia or macrocytosis develops — the indirect bilirubin rise can be an early marker.

3. Altered Enterohepatic Bilirubin Recycling Post-Stoma Reversal The gut microbiome after stoma reversal takes months to re-establish. Dysbiosis → altered β-glucuronidase activity → variable deconjugation and reabsorption of bilirubin from the reconstituted bowel. This is a transient but real physiological phenomenon in the 6–12 month window post-reversal, which fits the timeline perfectly.

Lower Priority (but check if above are negative)

Cause	Why lower now
AIHA / haemolysis	Would expect reticulocytosis, ↑LDH, ↓haptoglobin
Adalimumab DILI	Would cause conjugated rise + transaminitis, not isolated indirect
HBV reactivation	Excluded
Wilson's / PBSC	Excluded by biopsy

The Single Most Important Test Not Yet Mentioned

Serum B12 + methylmalonic acid (MMA)

MMA is more sensitive than serum B12 alone — it rises early in functional B12 deficiency even when serum B12 is borderline. This patient almost certainly needs lifelong parenteral B12 (IM or high-dose oral) post ileal resection, and if not already on it, deficiency is the prime suspect.

Bottom Line

With HBV negative, liver biopsy clean, good bowel habits, and no conjugated component — this is almost certainly Gilbert's syndrome (unmasked/exacerbated) ± B12-deficiency ineffective erythropoiesis, in the setting of post-ileal resection altered bilirubin enterohepatic cycling. The 6–7 month post-stoma-closure timing fits all three mechanisms simultaneously.

Check: B12, MMA, UGT1A1 genotype, CBC + reticulocyte count, LDH, haptoglobin. If all normal → Gilbert's confirmed by exclusion and genotyping, no further action needed beyond reassurance.

thanks, what is normocytic anemia relationship b/w underprdovction and periperal destruction

Reading File

Finding Sources

Reading File

Great source material. Here's a clear, structured explanation:

Normocytic Anemia: Underproduction vs. Peripheral Destruction

The MCV is normal (80–100 fL) in both categories — the key discriminator is the reticulocyte count, which reflects bone marrow output.

The Core Relationship

Normal RBC lifespan = 120 days
Steady state: production = destruction

Anemia occurs when this balance breaks:
  → Production ↓ (underproduction)   OR
  → Destruction ↑ (peripheral loss)

The marrow's response to each is opposite, and this is what the reticulocyte count reveals.

1. Underproduction (Hypoproliferative) — Low/Normal Reticulocyte Count

The marrow is failing to compensate — reticulocytes are low or inappropriately normal.

Cause	Mechanism
Anaemia of chronic disease (ACI)	Cytokine-mediated iron sequestration (hepcidin ↑), EPO resistance — very common in Crohn's
Renal disease	↓ EPO production from juxtaglomerular cells
Aplastic anaemia	Stem cell destruction/suppression
Pure red cell aplasia	Antibodies/T-cells targeting erythroid precursors
Hypothyroidism	Reduced EPO drive, reduced metabolic demand
Early iron/B12/folate deficiency	Before macrocytosis/microcytosis fully develops, can be normocytic
Myelophthisis (marrow infiltration)	Replaced marrow by malignancy, fibrosis

The marrow is not responding → reticulocytes don't rise despite anaemia.

2. Peripheral Destruction (Hyperproliferative) — High Reticulocyte Count

The marrow is intact and working hard to compensate → reticulocytes are elevated (>2% or absolute count >100×10⁹/L).

Cause	Mechanism
Haemolytic anaemia (autoimmune)	Antibody-coated RBCs destroyed by spleen/liver — relevant in Crohn's
Hereditary spherocytosis, G6PD deficiency	Intrinsic RBC membrane/enzyme defects
Microangiopathic haemolytic anaemia (MAHA)	Mechanical fragmentation (TTP, HUS, DIC) — schistocytes on smear
Acute blood loss/haemorrhage	Direct RBC loss → marrow upregulates; becomes normocytic acutely
Hypersplenism	Sequestration and destruction in enlarged spleen
Ineffective erythropoiesis (e.g. megaloblastic)	Intramedullary destruction — reticulocyte count may be paradoxically low-normal despite haemolysis happening inside the marrow

The Key Nuance: Ineffective Erythropoiesis (Relevant to Your Patient)

This is an important middle ground. In B12/folate deficiency, RBCs are destroyed inside the bone marrow before they're released (intramedullary haemolysis). The result:

Unconjugated bilirubin ↑ (haemolysis marker)
LDH ↑
But reticulocyte count is low or normal (despite haemolysis!) — because the defective cells never make it out of the marrow
MCV is usually macrocytic eventually, but early deficiency can be normocytic

This is why B12 deficiency after ileal resection can mimic an underproduction picture on reticulocyte count alone, while simultaneously raising unconjugated bilirubin.

Diagnostic Framework

Normocytic anaemia
        │
        ▼
Absolute reticulocyte count
        │
   ┌────┴────┐
  LOW       HIGH
(≤75×10⁹)  (>100×10⁹)
   │             │
Underproduction  Peripheral destruction
   │             │
- ACI          - Haemolysis (check LDH,
- Renal disease   haptoglobin, Coombs)
- Aplasia      - Acute blood loss
- Hypothyroid  - Microangiopathy
- Infiltration   (schistocytes on smear)
        │
   Normal/borderline
        │
   Consider:
   - Early deficiency states
   - Mixed picture
   - Ineffective erythropoiesis (B12↓)

In the Context of Your Crohn's Patient

Three mechanisms can coexist simultaneously:

ACI (underproduction) — from active inflammation, even on adalimumab
B12-deficiency ineffective erythropoiesis (intramedullary destruction) — post ileal resection
Possible AIHA (peripheral destruction) — extra-intestinal manifestation of Crohn's

All three can produce normocytic anaemia, and all three can be present together, which is why a reticulocyte count + peripheral smear + B12 + Coombs + LDH + haptoglobin panel is more informative than any single test.

— Henry's Clinical Diagnosis 23e, Normocytic Anemia; Harrison's 22E, Anaemia Definition and Classification; Goldman-Cecil Medicine, Normocytic Normochromic Anaemia

hct is total no . rbc in blood right /

Not quite — that's a common misconception worth clarifying.

Hematocrit (HCT) — What It Actually Is

HCT = the proportion (%) of whole blood volume occupied by red blood cells, not the total number of RBCs.

It is a volume fraction, not a count.

HCT = Volume of packed RBCs / Total blood volume × 100

Normal: ~42–52% in males, ~37–47% in females

So if HCT is 45%, it means 45 mL of every 100 mL of blood is RBCs — the remaining 55% is plasma + white cells + platelets (the "buffy coat").

How It's Measured

Old method (spun hematocrit): Blood is centrifuged in a capillary tube → RBCs pack to the bottom → the packed cell layer height is measured as a % of total column height.

Modern method (automated analyzers): HCT is calculated, not directly measured:

HCT = MCV × RBC count / 10

So on modern CBC reports, HCT is derived from the MCV and the RBC count together.

What Measures the Total Number of RBCs?

That's the RBC count — reported separately on CBC as cells × 10¹²/L (e.g., 4.5–5.5 × 10¹²/L in males).

The Distinction Matters Clinically

Parameter	What it measures
RBC count	Number of red cells per unit volume
HCT	% of blood volume that is red cells
Hb	Grams of haemoglobin per dL of blood
MCV	Average size of a single RBC (fL)

You can have a normal RBC count but low HCT if RBCs are small (microcytic — e.g. iron deficiency). Conversely, a low RBC count but near-normal HCT if RBCs are large (macrocytic — e.g. B12 deficiency).

This is exactly why MCV, HCT, RBC count, and Hb together give more information than any single value alone — and why the indices (MCV, MCH, MCHC) are calculated from their relationships.

osmosis means movement of water from high solute to low solute ? if yes then explain osmotic fralility tes spheroctosis

Small correction first, then the explanation.

Osmosis — Correction

Osmosis is the movement of water from low solute concentration to high solute concentration (i.e., from the more dilute side to the more concentrated side), across a semipermeable membrane.

Think of it this way: water moves toward where the solute is, trying to dilute it.

Low solute          High solute
(high water)  →→→  (low water)
         semipermeable membrane

The common confusion: people say "high to low" because they're thinking about the solute moving (as in diffusion). But in osmosis, it's water that moves, and it goes in the opposite direction — toward the higher solute concentration.

Osmotic Fragility Test in Hereditary Spherocytosis

Background: Normal RBC Shape

A normal biconcave disc RBC has excess membrane relative to its volume — this slack gives it flexibility to deform and, critically, to swell by taking in water before it lyses.

A normal RBC can increase its volume by ~70% before it bursts.

What Happens in Hereditary Spherocytosis (HS)

In HS, mutations in membrane skeletal proteins (spectrin, ankyrin, band 3, protein 4.2) cause loss of membrane surface area — bits of lipid bilayer pinch off as the cell passes through the spleen.

The RBC becomes a sphere (spherocyte) — the most volume-efficient shape for a given surface area. This means:

The cell is already at (or near) maximum volume for its membrane
It has no reserve capacity to swell further
It tolerates osmotic stress very poorly

The Test Itself

The patient's RBCs are placed in a series of progressively hypotonic saline solutions (from ~0.9% down to 0.0%):

Hypotonic solution → lower solute outside RBC
                   → water moves INTO the RBC (osmosis)
                   → RBC swells
                   → eventually lyses (haemolysis)

Saline concentration	Normal RBC	Spherocyte
0.9% (isotonic)	No lysis	No lysis
0.5%	No lysis	No lysis
0.4%	Begins to lyse	Already lysing
0.3%	50% lysis	Near complete lysis
0.1%	Complete lysis	Complete lysis

Normal RBCs begin to lyse around 0.4% saline and complete lysis around 0.2–0.3%.

Spherocytes lyse at higher saline concentrations (less hypotonic stress needed) — they are more fragile because they have no membrane slack to accommodate water entry.

Why Spherocytes Are More Fragile — The Geometry

Normal biconcave disc:
  Surface area >> volume → can swell before lysing

Spherocyte:
  Surface area ≈ minimum for its volume → already a sphere
  Any water entry → immediate membrane tension → lysis

A sphere has the lowest surface area-to-volume ratio of any shape. Once you're already spherical, there is no geometric reserve left. Even a small osmotic load ruptures the membrane.

The Result Plotted

The osmotic fragility curve shifts to the right in HS (lysis occurs at higher = less hypotonic saline concentrations):

% Haemolysis
100|              HS curve
   |           /
   |          /   Normal curve
50 |         /  /
   |        / /
   |       //
 0 |______//_____________
   0.8   0.5  0.3  0.1
        Saline % (w/v)

The HS curve is displaced rightward — fragility is increased.

Incubated Osmotic Fragility

If RBCs are incubated at 37°C for 24 hours before the test (no glucose), membrane loss is accentuated further, making the test even more sensitive for HS. This is the standard way to run the test to pick up mild cases.

Summary

	Normal RBC	Spherocyte (HS)
Shape	Biconcave disc	Sphere
Surface area reserve	High	None
Osmotic fragility	Normal	Increased
Lyses at	Very hypotonic saline	Mildly hypotonic saline
Mechanism	Has room to swell	Already maximally swollen for its membrane

The osmotic fragility test directly exploits the geometric consequence of membrane loss — spherocytes burst easily because they are already at the physical limit of their membrane.

This is a shared conversation. Sign in to Orris to start your own chat.